PHAP, NT, Control Peptide (Putative HLA DR-associated Protein, Putative Human HLA Class II Associated Protein, Acidic (Leucine-rich) Nuclear Phosphoprotein 32 Family Member B, ANP32B, Acidic Leucine-rich Nuclear Phosphoprotein 32 Family Member A, ANP32A, [PHAP, Control Peptide]
-
Catalog numberMBS619246
-
PricePlease ask
-
SizeNA
-
-
Products_typeAntibody
-
ReactivityHuman, Mouse, Rat
-
DescriptionIsotype or positive controls by peptides, antibodies and deactivated samples. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
PropertiesHuman proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
-
Gene target
-
Gene symbolHLA-DPA2, HLA-DOA, HLA-DQA1, HLA-N, HLA-DPB1, HLA-DQA2, HLA-DQB2, HLA-W, HLA-DRA, HLA-S
-
Short namePHAP, NT, Control Peptide (Putative HLA DR-associated Protein, Putative HLA Class II Associated Protein, Acidic (Leucine-rich) Phosphoprotein 32 Family Member B, ANP32B, Acidic Leucine-rich Phosphoprotein 32 Family Member A, ANP32A, [PHAP, Control Peptide]
-
TechniqueControl, peptide, controls, peptides
-
HostRabbit
-
SpeciesHuman, Humans
-
Alternative namePHAP, NT, reference short protein sequence (Putative Human leukocyte antigen DR-associated Protein, Putative H. sapiens Human leukocyte antigen Class II Associated Protein, Acidic (Leucine-rich) Nuclear Phosphoprotein 32 family Member B, ANP32B, Acidic Leucine-rich Nuclear Phosphoprotein 32 family Member A, ANP32A, [PHAP, reference short protein sequence]
-
Alternative techniquepeptides, controls
-
Tissuecontrol
-
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DP alpha 2 (pseudogene)
-
Synonyms gene
-
GenBank acession
-
Locus
-
Discovery year1986-01-01
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DO alpha
-
Synonyms gene
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- C1-set domain containing
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DQ alpha 1
-
Synonyms gene
-
Synonyms
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- C1-set domain containing
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class I, N (pseudogene)
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year2002-10-23
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DP beta 1
-
Synonyms gene
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- C1-set domain containing
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DQ alpha 2
-
Synonyms gene
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- C1-set domain containing
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DQ beta 2
-
Synonyms gene
-
GenBank acession
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
Pubmed identfication
-
Classification
- C1-set domain containing
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class I, W (pseudogene)
-
Synonyms gene
-
Synonyms gene name
- HLA-80 pseudogene
-
GenBank acession
-
Locus
-
Discovery year2004-01-16
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class II, DR alpha
-
Synonyms gene
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- C1-set domain containing
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namemajor histocompatibility complex, class I, S (pseudogene)
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year2002-10-23
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Histocompatibility complex
-
VEGA ID
-
Locus Specific Databases
MeSH Data
-
Name
-
ConceptScope note: Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion.
-
Tree numbers
- E01.370.225.625.120
- E01.370.225.812.385.120
- E05.200.625.120
- E05.200.812.385.120
- E05.478.594.385.120
-
Qualifiersethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data